insights_auto
Why is M1RN34 down ७.७२%?
Dive Deeperchevron_right
M1RN34:BVMF
Moderna Inc Bdr
R$ ४६.६५
arrow_downward
-७.७२%(-३.९०) 1D
अक्टोबर ६, १७:०६:०० GMT-३ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for M1RN34...
Open
R$ ५०.५४
High
R$ ५२.६०
Low
R$ ४६.६४
Mkt. cap
६९.९८ अरब
Avg. vol.
१.१५ लाख
Volume
०.००
52-wk high
R$ ५४.३८
52-wk low
R$ ६.०२
Shares outstanding
३९.९२ करोड
No. of employees
५ हजार
Open
R$ ५०.५४
High
R$ ५२.६०
Low
R$ ४६.६४
Mkt. cap
६९.९८ अरब
Avg. vol.
१.१५ लाख
Volume
०.००
52-wk high
R$ ५४.३८
52-wk low
R$ ६.०२
Shares outstanding
३९.९२ करोड
No. of employees
५ हजार
News stories
From web sources and news partners
Investor's Business Daily
·
७ घण्टा पहिले
Biotechs Sell Off — These Are The Biggest Losers
Investing.com
·
९ घण्टा पहिले
Why is Moderna stock sliding today?
TipRanks
·
९ घण्टा पहिले
Why Is Moderna Stock (MRNA) Falling Today, October 6?
Kalkine Media
·
१० घण्टा पहिले
What Does Joining the Nasdaq Mean for Moderna (NASDAQ:MRNA) Shares?
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc Bdr